BR9916865A - Composição farmacêutica em aerossol contendohfa 227 e hfa 134a - Google Patents

Composição farmacêutica em aerossol contendohfa 227 e hfa 134a

Info

Publication number
BR9916865A
BR9916865A BR9916865-0A BR9916865A BR9916865A BR 9916865 A BR9916865 A BR 9916865A BR 9916865 A BR9916865 A BR 9916865A BR 9916865 A BR9916865 A BR 9916865A
Authority
BR
Brazil
Prior art keywords
hfa
aerosol
pharmaceutical composition
composition containing
inhaler
Prior art date
Application number
BR9916865-0A
Other languages
English (en)
Inventor
Gaetano Brambilla
David Ganderton
Brian Meakin
Garzia Raffaella
Paolo Ventura
David Lewis
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BR9916865A publication Critical patent/BR9916865A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA EM AEROSSOL CONTENDOHFA 227 E HFA 134a". Em uma composição de solução para usoem um inalador de aerossol que consiste de um material ativo, umpropelente contendo um húdrofluoroalcano, um co-solvente e,opcionalmente, um componente de baixa volatilidade, o uso deuma mistura de HFA 134a e de HFA 227 permite modular odiâmetro aerodinâmico médio de massa (MMAD) das partículas emaerossol acionadas pelo inalador, para atingir regiões específicasdo trato respiratório. Além disso a dose de partículas finas (FPD) doingrediente ativo na composição aumenta pela redução do volumeda câmara dosificadora.
BR9916865-0A 1998-11-25 1999-11-22 Composição farmacêutica em aerossol contendohfa 227 e hfa 134a BR9916865A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002558A IT1303788B1 (it) 1998-11-25 1998-11-25 Formulazioni di aerosol medicinali.
PCT/EP1999/008959 WO2000030607A1 (en) 1998-11-25 1999-11-22 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a

Publications (1)

Publication Number Publication Date
BR9916865A true BR9916865A (pt) 2001-11-13

Family

ID=11381136

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916865-0A BR9916865A (pt) 1998-11-25 1999-11-22 Composição farmacêutica em aerossol contendohfa 227 e hfa 134a

Country Status (22)

Country Link
US (2) US6713047B1 (pt)
EP (1) EP1133277B1 (pt)
JP (1) JP2002530316A (pt)
KR (1) KR100794060B1 (pt)
CN (1) CN1177582C (pt)
AT (1) ATE368450T1 (pt)
AU (1) AU770529B2 (pt)
BR (1) BR9916865A (pt)
CA (1) CA2352483C (pt)
CY (1) CY1106904T1 (pt)
DE (1) DE69936730T2 (pt)
DK (1) DK1133277T3 (pt)
ES (1) ES2289832T3 (pt)
IL (1) IL143293A0 (pt)
IT (1) IT1303788B1 (pt)
MA (1) MA26763A1 (pt)
NO (1) NO330195B1 (pt)
NZ (1) NZ511923A (pt)
PT (1) PT1133277E (pt)
TR (1) TR200101442T2 (pt)
WO (1) WO2000030607A1 (pt)
ZA (1) ZA200104220B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
DE60031504T2 (de) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
GB2367011A (en) * 2000-08-26 2002-03-27 Glaxo Group Ltd Metered dose inhaler for salmeterol
ES2222294T3 (es) * 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
PT3536344T (pt) * 2002-03-01 2020-03-26 Chiesi Farm Spa Formulação superfina de formoterol
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
ME00420B (me) 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
AU2004272077A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
KR20070000476A (ko) * 2004-02-27 2007-01-02 키에시 파르마슈티시 엣스. 피. 에이. 압축화 계량된 도스흡입용 안정된 약제용액 제제
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN1583170A (zh) * 2004-06-10 2005-02-23 安米 用于抗病毒抗耐药菌的人溶菌酶药物及其制法
DK1809243T4 (da) 2004-07-02 2022-09-05 Boehringer Ingelheim Int Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP2011534A1 (en) * 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Metered dose inhaler actuator
WO2011150441A1 (en) * 2010-06-03 2011-12-08 Wholesome Biopharm Pty Ltd Medical aerosol formulation comprising ribavirin
RU2578975C2 (ru) * 2010-08-03 2016-03-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы
WO2014205030A1 (en) * 2013-06-19 2014-12-24 Map Pharmaceuticals, Inc. Pulmonary administration of rotigotine
US20160310410A1 (en) 2015-04-24 2016-10-27 Glenmark Specialty S.A. Pharmaceutical compositions comprising arformoterol and glycopyrronium
CN114796166A (zh) * 2021-01-29 2022-07-29 北京远大九和药业有限公司 一种含有萜烯类挥发油的气雾剂及其制备方法
CN114522143A (zh) * 2022-02-22 2022-05-24 暨南大学 用于吸入气雾剂的低制冷效应复合抛射剂及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH89518A (de) * 1919-03-22 1921-06-01 Croning Johannes Der Türdicke entsprechend einstellbares Gehäuse für Zylinderschlösser.
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
US3860618A (en) * 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
CA2094266C (en) 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
TR199701167T1 (xx) * 1995-04-14 1998-03-21 Glaxo Wellcome Inc. Albuterol i�in �l��lm�� doz inhaleri.
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
PT3536344T (pt) * 2002-03-01 2020-03-26 Chiesi Farm Spa Formulação superfina de formoterol

Also Published As

Publication number Publication date
AU770529B2 (en) 2004-02-26
WO2000030607A8 (en) 2001-03-22
JP2002530316A (ja) 2002-09-17
WO2000030607A1 (en) 2000-06-02
EP1133277B1 (en) 2007-08-01
DK1133277T3 (da) 2007-12-27
CA2352483C (en) 2009-01-20
DE69936730D1 (de) 2007-09-13
TR200101442T2 (tr) 2002-05-21
NO20012517L (no) 2001-07-23
ITMI982558A1 (it) 2000-05-25
US20040184993A1 (en) 2004-09-23
DE69936730T2 (de) 2008-04-30
AU1555300A (en) 2000-06-13
NO20012517D0 (no) 2001-05-22
CA2352483A1 (en) 2000-06-02
NZ511923A (en) 2003-10-31
ES2289832T3 (es) 2008-02-01
NO330195B1 (no) 2011-03-07
CY1106904T1 (el) 2012-05-23
IT1303788B1 (it) 2001-02-23
MA26763A1 (fr) 2004-12-20
US6713047B1 (en) 2004-03-30
KR100794060B1 (ko) 2008-01-10
PT1133277E (pt) 2007-10-09
ATE368450T1 (de) 2007-08-15
CN1331581A (zh) 2002-01-16
EP1133277A1 (en) 2001-09-19
KR20010080560A (ko) 2001-08-22
ZA200104220B (en) 2002-05-23
IL143293A0 (en) 2002-04-21
CN1177582C (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
BR9916865A (pt) Composição farmacêutica em aerossol contendohfa 227 e hfa 134a
BR9911351A (pt) Formulações farmacêuticas para aerossóis com duas ou mais substâncias ativas
DE69205177T2 (de) Pharmazeutische Aerosolformulierung.
AR018891A1 (es) Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol
ME00220B (me) Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
ATE216575T1 (de) Treibgasmischung für eine aerosolzubereitung
BR0303348A (pt) Formulações de aerossol para administração pulmonar de medicamentos com o intuito de produzir efeito sistêmico
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
AR009370A1 (es) UNA COMPOSICION FARMACEUTICA EN AEROSOL ADECUADA PARA LA ADMINISTRACION DE BUDESONIDA, UN PRODUCTO FARMACEUTICO QUE LA CONTIENE, UN METODO PARAADMINISTRAR BUDESONIDA Y USO DE UNA MEZCLA DE HFA 134a Y HFA 227
AR009231A1 (es) Formulaciones en aerosol de formoterol.
BR0112322A (pt) Nova formulação aerossol contendo uma molécula fluorada polar
EG22790A (en) A device for the administration of pressurized metered dose aerosols in hydrofluoroalkane propellants
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
JP2004529108A5 (pt)
AR060039A1 (es) Formulaciones novedosas
NZ231822A (en) Pharmaceutical aerosol formulation of sodium cromoglycate with chlorofluorocarbon propellant
YU87902A (sh) Stabilne farmaceutske formulacije rastvora za inhalatore odmerene doze pod pritiskom
GEP20053649B (en) Stable Pharmaceutical Solution Formulations for Pressurised Metered Dose Inhalers

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 9/12, A61K 47/06, A61K 47/10

Ipc: A61K 9/12 (2009.01), A61K 47/06 (2009.01), A61K 47

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE CONTRARIA O DISPOSTO NOS ARTIGOS 8O E 13 DA LPIE, ADICIONALMENTE, AS REIVINDICACOES 7 E 8 CONTRARIAM O DISPOSTO NO ARTIGO 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]